Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 76 Records) |
Query Trace: Fibrosis and F2[original query] |
---|
Liver disease in adults with ?1-antitrypsin deficiency. United European gastroenterology journal 2018 Jun 6 (5): 710-718. Mandorfer Mattias, Bucsics Theresa, Hutya Veronika, Schmid-Scherzer Karin, Schaefer Benedikt, Zoller Heinz, Ferlitsch Arnulf, Peck-Radosavljevic Markus, Trauner Michael, Ferenci Peter, Kneussl Meinhard, Reiberger Thom |
Two sides of a coin: GG genotype of C7 provides protection against fibrosis severity while showing a higher risk for hepatocellular carcinoma in patients with hepatitis C. Human immunology 2018 Jun . de Lima Raul Emídio, de Holanda Martins Cyntia Maria, do Carmo Rodrigo Feliciano, Aroucha Dayse Celia Barbosa Lins, Pereira Leila Maria Moreira Beltrão, Vasconcelos Luydson Richardson Silva, Moura Patríc |
Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2018 May 29 (3): 299-307. Besheer Tarek, Arafa Mona, El-Maksoud Mohamed Abd, Elalfy Hatem, Hasson Amany, Zalata Khaled, Elkashef Wagdi, Elshahawy Heba, Raafat Doaa, Elemshaty Wafaa, Elsayed Eman, Zaghloul Hosam, Razek Ahmed Abdel, El-Bendary Mahmo |
The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design. PloS one 2018 13 (5): e0197115. Jiménez-Sousa María Ángeles, Gómez-Moreno Ana Zaida, Pineda-Tenor Daniel, Medrano Luz Maria, Sánchez-Ruano Juan José, Fernández-Rodríguez Amanda, Artaza-Varasa Tomas, Saura-Montalbán José, Vázquez-Morón Sonia, Ryan Pablo, Resino Salvad |
[Interferon Lambda 4 RS12979860 C>T polymorphism is not associated with liver fibrosis in patients with hepatitis C]. Revista medica de Chile 2018 Jul 146 (7): 823-829. Brahm Javier, Urzúa Alvaro, Poniachik Jaime, Cáceres Dante D, Carreño Laura, Venegas Mauric |
Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2019 01 67 112-120. Jiménez-Sousa María A, Berenguer Juan, Fernández-Rodríguez Amanda, Medrano Luz María, Aldámiz-Echevarria Teresa, Pérez-Latorre Leire, Díez Cristina, Martín-Vicente María, Gutiérrez-Rivas Mónica, Martínez Isidoro, Resino Salvad |
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis. International journal of molecular sciences 2019 Jul 20 (15): . Wirtz Theresa Hildegard, Fischer Petra, Backhaus Christina, Bergmann Irina, Brandt Elisa Fabiana, Heinrichs Daniel, Koenen Maria Teresa, Schneider Kai Markus, Eggermann Thomas, Kurth Ingo, Stoppe Christian, Bernhagen Jürgen, Bruns Tony, Fischer Janett, Berg Thomas, Trautwein Christian, Berres Marie-Lui |
HPA-1a/1b could be considered a molecular predictor of poor prognosis in chronic hepatitis C. Revista da Sociedade Brasileira de Medicina Tropical 2019 Jun 52 e20170427. Grotto Rejane Maria Tommasini, Santos Francielle Martins, Picelli Natália, Silva Giovanni Faria, Ferrasi Adriana Camargo, Sarnighausen Valéria Cristina Rodrigues, Pardini Maria Inês de Moura Camp |
Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study. AIDS care 2019 7 32 (6): 762-769. Piekarska A, Jab?onowska E, Garlicki A, Sitko M, Mazur W, Jaroszewicz J, Czauz-Andrzejuk A, Buczy?ska I, Simon K, Lorenc B, Dybowska D, Halota W, Paw?owska M, Dobracka B, Berak H, Horban A, Tudrujek-Zdunek M, Tomasiewicz K, Janczewska E, Socha ?, Laurans ?, Parczewski M, Zar?bska-Michaluk D, Pabjan P, Belica-Wdowik T, Baka-?wierz B, Dero? Z, Krygier R, Klapaczy?ski J, Citko J, Berkan-Kawi?ska A, Flisiak |
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population. Annals of hepatology 2019 Apr . Mazo Daniel F, Malta Fernanda M, Stefano Jose Tadeu, Salles Ana Paula M, Gomes-Gouvea Michele S, Nastri Ana Catharina S, Almeida Jazon R, Pinho Joao Renato R, Carrilho Flair J, Oliveira Claudia |
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis. Acta bio-medica : Atenei Parmensis 2019 05 90 (2): 187-196. Pisaturo Mariantonietta, Russo Antonio, Onorato Lorenzo, Coppola Nico |
Cirrhosis risk score of the donor organ predicts early fibrosis progression after liver transplantation. Journal of gastrointestinal and liver diseases : JGLD 2019 3 28 (1): 53-61. Zimmermann Anca, Darstein Felix, Hoppe-Lotichius Maria, Toenges Gerrit, Lautem Anja, Abel Frédéric, Schad Arno, Mittler Jens, Vollmar Johanna, Grimm Daniel, Lang Hauke, Galle Peter R, Zimmermann Tim, Schuppan Detl |
Human platelet antigens polymorphisms; association to the development of liver fibrosis in patients with chronic hepatitis C. Journal of medical virology 2019 Feb . Ghasemi Ali, Zadsar Maryam, Shaiegan Mojgan, Samiei Shahram, Namvar Ali, Rasouli Mahboobeh, Moosanejad Molo |
Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. Journal of gastroenterology and hepatology 2019 Nov . Liu Wen-Yue, Zheng Kenneth I, Pan Xiao-Yan, Ma Hong-Lei, Zhu Pei-Wu, Wu Xi-Xi, Rios Rafael S, Targher Giovanni, Byrne Christopher D, Wang Xiao-Dong, Chen Yong-Ping, Zheng Ming-H |
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study. Liver international : official journal of the International Association for the Study of the Liver 2019 11 40 (5): 1042-1051. Asselah Tarik, Pol Stanislas, Hezode Christophe, Loustaud-Ratti Veronique, Leroy Vincent, Ahmed Si Nafa Si, Ozenne Violaine, Bronowicki Jean-Pierre, Larrey Dominique, Tran Albert, Alric Laurent, Nguyen-Khac Eric, Robertson Michael N, Hanna George J, Brown Deborah, Asante-Appiah Ernest, Su Feng-Hsiu, Hwang Peggy, Hall Jessie Durrand, Guidoum Amir, Hagen Karin, Haber Barbara A, Talwani Rohit, Serfaty Lawren |
Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment. World journal of gastroenterology 2019 10 25 (38): 5883-5896. Gil-García Ana Isabel, Madejón Antonio, Francisco-Recuero Irene, López-López Ana, Villafranca Emiliana, Romero Miriam, García Araceli, Olveira Antonio, Mena Rocío, Larrubia Juan Ramón, García-Samaniego Javi |
Hepatitis C virus clearance and less liver damage in patients with high cholesterol, low-density lipoprotein cholesterol and APOE ?4 allele. World journal of gastroenterology 2019 10 25 (38): 5826-5837. Gonzalez-Aldaco Karina, Roman Sonia, Torres-Valadez Rafael, Ojeda-Granados Claudia, Torres-Reyes Luis A, Panduro Artu |
Genetic variant c.711A>T in the hepatobiliary phospholipid transporter ABCB4 is associated with significant liver fibrosis. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2020 9 71 (3): . Smyk W, Weber S N, Hall R, Gruenhage F, Lammert F, Krawczyk |
Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis. Biology 2020 Apr 9 (4): . El-Derany Marwa |
Inflammasome genes polymorphisms may influence the development of hepatitis C in the Amazonas, Brazil. PloS one 2021 16 (6): e0253470. Toro Diana Mota, Ramasawmy Rajendranath, Silva Neto Pedro Vieira, Pereira Grenda Leite, Sarmento Priscila Santos, Dray Hanna Lara Silva Negreiros, Sousa Keyla Santos, Affonso Juliana Santos, Silva Jéssica Albuquerque, Garcia Nadja Pinto, Barbieri Marilú Victória, Victória Flamir Silva, Donadi Eduardo Antônio, Costa Allyson Guimarães, Ogusku Mauricio Morishi, Sadahiro Aya, Tarragô Andréa Monteiro, Malheiro Adria |
Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis. World journal of gastroenterology 2021 Mar 27 (11): 1064-1075. Nascimento José Carlos Rodrigues, Pereira Lianna C, Rêgo Juliana Magalhães C, Dias Ronaldo P, Silva Paulo Goberlânio B, Sobrinho Silvio Alencar C, Coelho Gustavo R, Brasil Ivelise Regina C, Oliveira-Filho Edmilson F, Owen James S, Toniutto Pierluigi, Oriá Reinaldo |
PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study. BMC gastroenterology 2022 Aug 22 (1): 401. Rauff Bisma, Alzahrani Badr, Chudhary Shafiq A, Nasir Bilal, Mahmood Saqib, Bhinder Munir Ahmad, Faheem Muhammad, Amar A |
The presence of interferon affects the progression of non-alcoholic fatty liver disease. Genes and immunity 2022 6 23 (5): 157-165. Møhlenberg Michelle, Eriksen Peter Lykke, Laursen Tea Lund, Nielsen Mette Bak, Hamilton Dutoit Stephen Jacques, Grønbæk Henning, Hartmann Rune, Thomsen Karen Loui |
Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants. PloS one 2022 17 (6): e0269641. Chuaypen Natthaya, Siripongsakun Surachate, Hiranrat Pantajaree, Tanpowpong Natthaporn, Avihingsanon Anchalee, Tangkijvanich Pis |
Non-Alcoholic Fatty Liver Disease in Long-Term Type 2 Diabetes: Role of rs738409 PNPLA3 and rs499765 FGF21 Polymorphisms and Serum Biomarkers. Molecules (Basel, Switzerland) 2022 5 27 (10): . Mana Mauy Frujuello, Parisi Maria Cândida R, Correa-Giannella Maria Lucia, Neto Arnaldo Moura, Yamanaka Ademar, Cunha-Silva Marlone, Cavaleiro Ana Mercedes, Dos Santos Cristina Rodrigues, Pavan Célia Regina, Sevá-Pereira Tiago, Dertkigil Sergio S J, Mazo Daniel |
Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents. Life (Basel, Switzerland) 2023 9 13 (9): . Naim Abu-Freha, Osama Abu-Kosh, David Yardeni, Yaffa Ashur, Muhammad Abu-Arar, Baha Yousef, Shulamit Monitin, Sarah Weissmann, Ohad Etzi |
Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease. Digestive diseases and sciences 2023 12 . Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Paulo Henrique Condeixa Franca, Claudia Regina Lopes Cardoso, Gil Fernando Salles, Cristiane A Villela-Noguei |
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease. Journal of hepatology 2023 10 . Federico Salomone, Rosaria Maria Pipitone, Francesco Malvestiti, Miriam Longo, Angela Maria Amorini, Alfio Distefano, Elia Casirati, Ester Ciociola, Nunzio Iraci, Loredana Leggio, Rossella Zito, Nunzio Vicario, Concetta Saoca, Grazia Pennisi, Daniela Cabibi, Giuseppe Lazzarino, Anna Ludovica Fracanzani, Paola Dongiovanni, Luca Valenti, Salvatore Petta, Giovanni Li Volti, Stefania Grimau |
Investigating the association of toll-like receptor 9 rs5743836, rs352140, and rs187084 gene polymorphisms and their mRNA levels with different hepatic fibrosis stages of non-alcoholic fatty liver patients compared to healthy controls. Molecular biology research communications 2023 1 11 (3): 119-126. Rezaie Azadeh, Nasiri Meysam, Hatami Behzad, Baghaie Kaveh, Asadzadeh-Aghdaei Hamid, Zali Mohammad Re |
The Impact of interferon lambda 3 Polymorphism on Hepato-Cellular Carcinoma Progression in Hepatitis C Virus Patients: Treatment-Naïve and Experienced. Asian Pacific journal of cancer prevention : APJCP 2023 1 24 (1): 215-221. Abd Elrahman Mohamed, Ibrahim Marwa K, Khairy Ahmed, Yosry Ayman, Zayed Naglaa, Tawefeek Salwa, Barakat Amal Z, Elbatae Hassan, Bader El Din Noha |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: